Yu Lan

614 total citations
19 papers, 144 citations indexed

About

Yu Lan is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Lan has authored 19 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Lan's work include Helicobacter pylori-related gastroenterology studies (11 papers), Gastroesophageal reflux and treatments (3 papers) and Eosinophilic Esophagitis (3 papers). Yu Lan is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (11 papers), Gastroesophageal reflux and treatments (3 papers) and Eosinophilic Esophagitis (3 papers). Yu Lan collaborates with scholars based in China, Hong Kong and United Kingdom. Yu Lan's co-authors include Deliang Fu, Lingyun Zhang, Shuo Zhang, Liang Qiao, Yuexia Zhang, Xi Wu, Xumin Zhang, Shuai Wang, Xiaojin Zhang and Yan Shi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Science Advances.

In The Last Decade

Yu Lan

13 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Lan China 8 74 46 37 28 16 19 144
Longbao Yang China 8 36 0.5× 52 1.1× 26 0.7× 26 0.9× 8 0.5× 25 175
Łukasz Krupa Poland 7 39 0.5× 52 1.1× 12 0.3× 28 1.0× 12 0.8× 19 192
Zahidul Alam Bangladesh 5 25 0.3× 61 1.3× 23 0.6× 9 0.3× 22 1.4× 9 136
Yusuke Yoshimatsu Japan 8 44 0.6× 61 1.3× 19 0.5× 11 0.4× 47 2.9× 23 184
Yuqin Shen China 7 42 0.6× 143 3.1× 18 0.5× 22 0.8× 16 1.0× 15 279
Zainab Abbas Iraq 5 44 0.6× 18 0.4× 32 0.9× 51 1.8× 54 3.4× 17 190
Tsuyotoshi Tsuji Japan 10 82 1.1× 115 2.5× 85 2.3× 40 1.4× 8 0.5× 26 318
Aleksandra Sokić-Milutinović Serbia 11 144 1.9× 37 0.8× 45 1.2× 36 1.3× 56 3.5× 34 281
Clara Mancuso Italy 8 56 0.8× 33 0.7× 33 0.9× 7 0.3× 41 2.6× 10 193

Countries citing papers authored by Yu Lan

Since Specialization
Citations

This map shows the geographic impact of Yu Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lan more than expected).

Fields of papers citing papers by Yu Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lan. The network helps show where Yu Lan may publish in the future.

Co-authorship network of co-authors of Yu Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lan. A scholar is included among the top collaborators of Yu Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lan. Yu Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Jingheng, Mengran Du, Qi Shi, et al.. (2025). Brain-derived extracellular vesicles circUsp32 polarized macrophages causing acute kidney injury after traumatic brain injury. Science Advances. 11(48). eadz1243–eadz1243.
2.
Ning, Huan, Yu Lan, Qianqian Huang, et al.. (2025). Enhancing public health surveillance: SARIMAX model incorporating Baidu search index for HCV prediction in China. BMC Medical Research Methodology. 25(1). 108–108.
3.
Zhao, Jing, Wanting Xu, Fei Zhou, et al.. (2025). Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches. Nature Reviews Clinical Oncology. 23(1). 63–83.
4.
Zhang, Lingyun, Shuo Yang, Xiao-Lu Chen, et al.. (2024). The Efficacy and Safety of Minocycline‐Containing Quadruple Therapies Against Helicobacter pylori Infection: A Retrospective Cohort Study. Infection and Drug Resistance. Volume 17. 2513–2529.
6.
Fu, Deliang, et al.. (2020). GFAT1/HBP/O‐GlcNAcylation Axis Regulates β‐Catenin Activity to Promote Pancreatic Cancer Aggressiveness. BioMed Research International. 2020(1). 1921609–1921609. 30 indexed citations
7.
Wu, Xi, et al.. (2020). Beneficial effects of lactitol on the composition of gut microbiota in constipated patients. Journal of Digestive Diseases. 21(8). 445–453. 19 indexed citations
8.
9.
Zhang, Lingyun, et al.. (2019). Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori. Gastroenterology Research and Practice. 2019. 1–6. 22 indexed citations
10.
Zhang, Xumin, et al.. (2019). Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis. World Journal of Gastroenterology. 25(39). 6025–6040. 15 indexed citations
11.
Yang, Chang, Ying Xuan Chen, Yu Yang, et al.. (2019). Validation in China of a non‐invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease. Journal of Digestive Diseases. 20(6). 278–287. 15 indexed citations
12.
Mou, Haibo, et al.. (2018). Efficacy and safety of apatinib in refractory unresectable and metastatic cholangiocarcinoma: A retrospective analysis.. Journal of Clinical Oncology. 36(15_suppl). e16123–e16123. 3 indexed citations
14.
Wang, Yulin, et al.. (2017). Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population.. PubMed. 8(4). 45–52. 7 indexed citations
15.
Lan, Yu, et al.. (2013). [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].. PubMed. 35(8). 623–6. 7 indexed citations
16.
Liang, Xueya, et al.. (2012). [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].. PubMed. 51(7). 513–5.
17.
Lan, Yu, et al.. (2011). Sequential therapy versus standard triple therapy for Helicobacter pylori eradication. World Chinese Journal of Digestology. 19(29). 3100–3100. 6 indexed citations
18.
Li, Li, Yu Lan, & Xiaojin Zhang. (2009). A nonalcoholic fatty liver survey of 1655 medical staffs and analysis of relative factors. World Chinese Journal of Digestology. 17(17). 1782–1782. 1 indexed citations
19.
Zhang, Fanglin, Yong Liu, Yu Lan, et al.. (2004). Construction and identification of recombinant adenovirus containing chimeric gene G1S0.7 of Hantaan virus. The Journal of Immunology. 22(12). 1057–1060. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026